Peritoneovenous Shunt.
Malik TF, Anjum F.
2023 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Peritoneovenous shunt (PVS) for malignant ascites. An analysis of outcome.
Smith DA, Weaver DW, Bouwman DL.
Am Surg. 1989 Jul;55(7):445-9.
The peritoneovenous shunt: expectations and reality.
Moskovitz M.
Am J Gastroenterol. 1990 Aug;85(8):917-29.
Peritoneovenous Shunt for Intractable Ascites in Children: A Series of 4 Cases.
Defert C, Marret JB, Lacaille F, Sissaoui S, Dupic L, Lardy H, Capito C, Chardot C.
J Pediatr Gastroenterol Nutr. 2021 Jul 1;73(1):e7-e10. doi: 10.1097/MPG.0000000000003131.
Coagulopathy post peritoneovenous shunt.
LeVeen HH, Ip M, Ahmed N, Hutto RB, LeVeen EG.
Ann Surg. 1987 Mar;205(3):305-11. doi: 10.1097/00000658-198703000-00015.
Peritoneovenous shunt scintigraphy to assess shunt patency in patients with refractory ascites.
Senthil R, Sundaraiya S, Perumalla R, Rela M.
J Clin Exp Hepatol. 2013 Dec;3(4):347-50. doi: 10.1016/j.jceh.2013.05.012. Epub 2013 Jun 27.
The place of the peritoneovenous shunt in the treatment of ascites.
LeVeen EG, LeVeen HH.
ASAIO Trans. 1989 Apr-Jun;35(2):165-8. doi: 10.1097/00002480-198904000-00011.
Radiologically Placed Peritoneovenous Shunt is an Acceptable Treatment Alternative for Refractory Ascites Due to End-Stage Liver Disease.
Bakhtiar M, Forde KA, Nadolski GJ, Soulen MC, Weinberg EM.
J Vasc Interv Radiol. 2021 Nov;32(11):1606-1614. doi: 10.1016/j.jvir.2021.08.003. Epub 2021 Aug 17.
The influence of a peritoneovenous shunt for cirrhotic and malignant intractable ascites on renal function.
Segawa T, Kato K, Kawashima K, Suzuki T, Ehara S.
Acta Radiol Open. 2018 Mar 26;7(3):2058460118764208. doi: 10.1177/2058460118764208. eCollection 2018 Mar.
Role of different techniques for the placement of Denver peritoneovenous shunt (PVS) in malignant ascites.
Clara R, Righi D, Bortolini M, Cornaglia S, Ruffino MA, Zanon C.
Surg Laparosc Endosc Percutan Tech. 2004 Aug;14(4):222-5. doi: 10.1097/01.sle.0000136675.54624.16.
